Skip to main content
Back to Qiming Venture Partners

Qiming Venture Partners's Life Science Portfolio

Browse 6 Life Science companies funded by Qiming Venture Partners. See funding amounts, founder contacts, and investment details.

Life Science Companies
6
Total Funding in Life Science
$470.7M

Life Science Portfolio Companies (6)

Export
BiotechnologyLife ScienceTherapeutics

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam, The Netherlands
October 2025
$35.2M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Seattle, United States
August 2024
$144.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceOncology

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Vancouver, Canada
April 2023
$142.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Powering precision proteomics to enable to the earliest detection of disease.

Fremont, United States
January 2026
$50.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

ChemLex is a chemical synthesis CRO that was founded by Magera Technology.

Shanghai, China
December 2025
$45.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

19,000+ verified contacts

Explore Qiming Venture Partners's Full Portfolio

View all companies funded by Qiming Venture Partners across every industry and funding stage.

View Full Qiming Venture Partners Portfolio